KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $41,679,000 | +58.1% | 231,794 | -8.9% | 0.01% | +57.1% |
| Q2 2017 | $26,366,000 | +31.7% | 254,324 | -0.3% | 0.01% | +16.7% |
| Q1 2017 | $20,014,000 | +117.5% | 254,995 | +24.2% | 0.01% | +100.0% |
| Q4 2016 | $9,202,000 | -20.6% | 205,243 | -1.1% | 0.00% | 0.0% |
| Q3 2016 | $11,589,000 | +10.3% | 207,471 | -1.3% | 0.00% | 0.0% |
| Q2 2016 | $10,507,000 | +13.6% | 210,127 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $9,249,000 | -16.9% | 201,472 | +11.6% | 0.00% | 0.0% |
| Q4 2015 | $11,127,000 | +29.7% | 180,591 | +17.3% | 0.00% | 0.0% |
| Q3 2015 | $8,576,000 | +4.7% | 154,013 | +14.7% | 0.00% | +50.0% |
| Q2 2015 | $8,188,000 | +105.9% | 134,310 | +94.8% | 0.00% | +100.0% |
| Q1 2015 | $3,977,000 | +18.1% | 68,940 | +18.1% | 0.00% | 0.0% |
| Q4 2014 | $3,368,000 | +308.2% | 58,392 | +101.8% | 0.00% | – |
| Q3 2014 | $825,000 | – | 28,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|